Medical Research
(H30)
990 on File
SLAY SARCOMA RESEARCH INITIATIVE
Financial strength (30%)
45/100
Reliability (20%)
50/100
Effectiveness (25%)
61/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$49K
Total Revenue
$52K
Total Expenses
$2K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
96.2%
Fundraising Efficiency
55.5%
Operating Reserve
0.55x
Liability-to-Asset
N/A
Revenue Diversification
78.3%
Compared with Peers
FY 2023
Compared with 1,152 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
96.2% | 80.3% |
P10P90
|
Above median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
55.5% | 39.4% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
0.6 mo | 37.0 mo |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
78.3% | 100.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
8.5% | -1.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
16.6% | -3.6% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-6.5% | 12.7% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $49K | $52K | $2K | 96.2% | — |
| 2022 | $45K | $45K | $6K | 80.8% | — |
| 2021 | $60K | $37K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.